Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Venous Thromboembolism”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Large-scale testing (Phase 3)Study completedNCT02798471
What this trial is testing

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism (VTE)Pulmonary EmbolismDeep Vein Thrombosis (DVT)
Daiichi Sankyo 290
Not applicableEnded earlyNCT05966740
What this trial is testing

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 5
Post-approval studies (Phase 4)Study completedNCT07618988
What this trial is testing

Rivaroxaban in Pediatric Patients With DVT

Who this might be right for
Pediatric Venous Thromboembolism
Ain Shams University 60
Not applicableActive Not RecruitingNCT06193863
What this trial is testing

An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure

Who this might be right for
Prevention of Venous ThromboembolismCongenital Heart DiseaseFontan Procedure+1 more
Bayer 61
Not applicableStudy completedNCT04574895
What this trial is testing

Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events

Who this might be right for
Venous ThromboembolismPediatricsDeep Vein Thrombosis+1 more
Vanderbilt University Medical Center 17,427
Not applicableStudy completedNCT03068923
What this trial is testing

Thrombosis Outcomes in Pediatric Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
University of Texas Southwestern Medical Center 120
Testing effectiveness (Phase 2)Study completedNCT00952380
What this trial is testing

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Who this might be right for
Venous Thromboembolism
Pfizer 38
Early research (Phase 1)Study completedNCT01145859
What this trial is testing

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Who this might be right for
Venous ThrombosisPediatrics
Bayer 59
Large-scale testing (Phase 3)Not Yet RecruitingNCT06628778
What this trial is testing

Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).

Who this might be right for
Venous Thromboembolism (VTE)
Johns Hopkins All Children's Hospital 802
Not applicableStudy completedNCT02037607
What this trial is testing

Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures

Who this might be right for
Deep Vein Thrombosis
Indiana University 100
Post-approval studies (Phase 4)Study completedNCT02464969
What this trial is testing

Apixaban for the Acute Treatment of Venous Thromboembolism in Children

Who this might be right for
Venous Thromboembolism
Bristol-Myers Squibb 229
Testing effectiveness (Phase 2)Study completedNCT02564718
What this trial is testing

Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates

Who this might be right for
Thromboembolism
Bayer 10
Early research (Phase 1)Study completedNCT01707394
What this trial is testing

Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

Who this might be right for
Thromboembolism
Bristol-Myers Squibb 49
Not applicableStudy completedNCT01140386
What this trial is testing

Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Pediatric Patients

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPediatrics
Penn State University 25
Not applicableStudy completedNCT04117217
What this trial is testing

Risk Factors for Thrombosis in Children With Central Venous Lines

Who this might be right for
Pediatric Venous Thromboembolism
University of Arizona 200
Early research (Phase 1)Study completedNCT02303431
What this trial is testing

Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study

Who this might be right for
Deep Vein ThrombosisVenous Thromboembolism
Daiichi Sankyo 66
Large-scale testing (Phase 3)Study completedNCT02234843
What this trial is testing

EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis

Who this might be right for
Venous Thromboembolism
Bayer 500
Testing effectiveness (Phase 2)Study completedNCT02309411
What this trial is testing

EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis

Who this might be right for
Venous Thromboembolism
Bayer 46
Not applicableStudy completedNCT01137578
What this trial is testing

Pediatric Catheter-related Thrombosis Imaging Study

Who this might be right for
Thrombosis
Bristol-Myers Squibb 151
Early research (Phase 1)Ended earlyNCT01195727
What this trial is testing

Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter

Who this might be right for
Venous Thromboembolism
Bristol-Myers Squibb 13
Next Page